- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02013024
The Effect of Vitrification Versus Slow Freezing on Day 3: a Randomised Controlled Trial.
February 4, 2015 updated by: Sophie Debrock
Randomized controlled trial (RCT) testing the hypothesis that vitrification is superior to slow freezing.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
417
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- Leuven University Fertility Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients (with female age < 40 years)
- Patients undergoing a 1st oocyte retrieval for an IVF/Intracytoplasmatic Sperm Injection (ICSI) treatment
- Patients planned for an embryo transfer on day 3.
- Patients with supernumerary embryos of sufficient quality for freezing/vitrifying on day 3.
- Fresh personal (own oocytes)
- One inclusion in the study per patient.
Exclusion Criteria:
- Patients undergoing a 2nd or higher ranked oocyte retrieval after a fresh cycle with failed pregnancy.
- Female age ≥ 40 year
- Patients with Preimplantation Genetic Diagnosis (PGD)
- Patients with donor oocytes
- Patients with positive serology whose embryos may not be frozen.
- Patients planned for a transfer on day 2 or day 5.
- Patients receiving assisted hatching in the embryo transfer in the frozen cycles.
- Patients who have been included in the study before.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: cryopreservation technique
slow freezing cryopreservation technique
|
|
|
Active Comparator: vitrification cryopreservation technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Life birth rate per embryo thawed
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
live birth rate per embryo transferred
Time Frame: 3
|
3
|
|
survival rate
Time Frame: 3 year
|
3 year
|
|
implantation rate per embryo transferred
Time Frame: 3 years
|
3 years
|
|
implantation rate per embryo thawed
Time Frame: 3 years
|
3 years
|
|
abortion rate
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas M D'Hooghe, Prof Dr, Universitaire Ziekenhuizen KU Leuven
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
December 11, 2013
First Submitted That Met QC Criteria
December 11, 2013
First Posted (Estimate)
December 17, 2013
Study Record Updates
Last Update Posted (Estimate)
February 5, 2015
Last Update Submitted That Met QC Criteria
February 4, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- S53410
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cryopreservation of Embryos
-
Chinese University of Hong KongNot yet recruitingIn Vitro Fertilization (IVF) | Assisted Reproductive Techniques | Cryopreservation of Embryos | Frozen Embryo Transfer (FET) | Pregnancy Outcome After in Vitro Fertilization (IVF)Hong Kong, United Kingdom
-
V.K.V. American Hospital, IstanbulCompletedFertilization in Vitro | Preservation of Supernumerary EmbryosTurkey
-
Soroka University Medical CenterBen-Gurion University of the NegevUnknownNormal Healthy EmbryosIsrael
-
University Hospital, GasthuisbergCompleted
-
University Hospital, GasthuisbergCompletedthe Focus of This Study is to Measure the Intra- and Interobserver Agreement for the Evaluation of Early Stage EmbryosBelgium
-
EMD SeronoCompleted
-
IRCCS San RaffaeleActive, not recruiting
-
V.K.V. American Hospital, IstanbulCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCryopreservationItaly
Clinical Trials on cryopreservation technique
-
Bruce Shapiro M.D.Completed
-
Central Hospital, Nancy, FranceUnknown
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Hadassah Medical OrganizationUnknown
-
University Hospital, Clermont-FerrandCompleted
-
Overture LifeRecruiting
-
Instituto Valenciano de Infertilidad, IVI AlicanteIgenomixCompleted
-
Vlad RadulescuCompletedCancer | Infertility | Rheumatologic Disorder | Hematologic DisorderUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
St. Justine's HospitalNot yet recruitingCancer | Infertility | Ovarian Failure | Hematologic DisorderCanada